{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:50:00Z","timestamp":1782719400748,"version":"3.54.5"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/jcp.0b013e3181a45ed0","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:47:24Z","timestamp":1242910044000},"page":"210-215","source":"Crossref","is-referenced-by-count":55,"title":["Association of Posttraumatic Stress Disorder With Increased Prevalence of Metabolic Syndrome"],"prefix":"10.1097","volume":"29","author":[{"given":"Hua","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Lanouette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunder","family":"Mudaliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Folsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikriskna","family":"Khandrika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle K.","family":"Glorioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip V.","family":"Jeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome.","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","article-title":"NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.","volume":"52","author":"Alexander","year":"2003","journal-title":"Diabetes"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","article-title":"Increasing prevalence of the metabolic syndrome among US adults.","volume":"27","author":"Ford","year":"2004","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"R4-3-20210128","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders.","volume":"118","author":"Casey","year":"2005","journal-title":"Am J Med"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"R6-3-20210128","first-page":"76","article-title":"Mental disorders and metabolic syndrome: a fatamorgana or warning reality?","volume":"19","author":"Jakovljevic","year":"2007","journal-title":"Psychiatr Danub"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disord"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.05.030","article-title":"Modal subcomponents of metabolic syndrome in patients with bipolar disorder.","volume":"106","author":"Cardenas","year":"2008","journal-title":"J Affect Disord"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.4088\/JCP.v67n0913","article-title":"Metabolic syndrome and depression: a cross-sectional analysis.","volume":"67","author":"Heiskanen","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4088\/JCP.v63n1002","article-title":"The effects of novel antipsychotics on glucose and lipid levels.","volume":"63","author":"Wirshing","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2004.03.024","article-title":"Atypical antipsychotics and glucose dysregulation: a systematic review.","volume":"71","author":"Jin","year":"2004","journal-title":"Schizophr Res"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","article-title":"Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.","volume":"16","author":"Butterfield","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.","volume":"23","author":"Hamner","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004850-200111000-00003","article-title":"Olanzapine treatment for post-traumatic stress disorder: an open-label study.","volume":"16","author":"Petty","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.","volume":"159","author":"Stein","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.yic.0000185021.48279.00","article-title":"Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans.","volume":"21","author":"Lambert","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3325\/cmj.2008.4.459","article-title":"Psychopharmacotherapy of posttraumatic stress disorder.","volume":"49","author":"Kozaric-Kovacic","year":"2008","journal-title":"Croat Med J"},{"key":"R18-3-20210128","first-page":"169","article-title":"Metabolic syndrome, somatic and psychiatric comorbidity in war veterans with post-traumatic stress disorder: preliminary findings.","volume":"18","author":"Jakovljevic","year":"2006","journal-title":"Psychiatr Danub"},{"key":"R19-3-20210128","first-page":"227","article-title":"Police trauma and cardiovascular disease: association between PTSD symptoms and metabolic syndrome.","volume":"8","author":"Violanti","year":"2006","journal-title":"Int J Emerg Ment Health"},{"key":"R20-3-20210128","first-page":"68","article-title":"Metabolic syndrome and combat post-traumatic stress disorder intensity: preliminary findings.","volume":"19","author":"Babic","year":"2007","journal-title":"Psychiatr Danub"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ps.55.1.82","article-title":"Comparison of comorbid physical illnesses among veterans with PTSD and veterans with alcohol dependence.","volume":"55","author":"David","year":"2004","journal-title":"Psychiatr Serv"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.164.4.394","article-title":"Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment.","volume":"164","author":"Dobie","year":"2004","journal-title":"Arch Intern Med"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1600-0447.2007.01071.x","article-title":"Posttraumatic stress disorder as a risk factor for obesity among male military veterans.","volume":"116","author":"Vieweg","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/PCC.v08n0104","article-title":"Posttraumatic stress disorder in male military veterans with comorbid overweight and obesity: psychotropic, antihypertensive, and metabolic medications.","volume":"8","author":"Vieweg","year":"2006","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2007.08.013","article-title":"Abnormal serum lipid profile in Brazilian police officers with post-traumatic stress disorder.","volume":"107","author":"Maia","year":"2008","journal-title":"J Affect Disord"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1176\/appi.ps.53.7.848","article-title":"Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder.","volume":"53","author":"Weisberg","year":"2002","journal-title":"Psychiatr Serv"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ypmed.2004.07.013","article-title":"Self-reported diabetes and posttraumatic stress disorder among adults in the community.","volume":"40","author":"Goodwin","year":"2005","journal-title":"Prev Med"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10865-006-9067-2","article-title":"Post-traumatic stress disorder and diabetes: co-morbidity and outcomes in a male veterans sample.","volume":"29","author":"Trief","year":"2006","journal-title":"J Behav Med"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jts.20129","article-title":"Associations between psychological trauma and physical illness in primary care.","volume":"19","author":"Norman","year":"2006","journal-title":"J Trauma Stress"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02884839","article-title":"Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research.","volume":"21","author":"Boscarino","year":"1999","journal-title":"Ann Behav Med"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP White Paper: update on the use of antipsychotic drugs in elderly persons with dementia.","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4088\/JCP.v69n0602","article-title":"Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.","volume":"69","author":"Salzman","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","article-title":"Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale (CIRS).","volume":"41","author":"Miller","year":"1992","journal-title":"Psychiatry Res"},{"key":"R35-3-20210128","first-page":"870","article-title":"Measurements of acute cerebral infarction: a clinical examination scale.","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness.","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R40-3-20210128","first-page":"3","article-title":"Abnormal Involuntary Movement Scale (AIMS).","volume":"4","year":"1975","journal-title":"Early Clinical Drug Evaluation Unit Intercom"},{"key":"R41-3-20210128","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The Mini-Mental State Examination.","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus.","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.ijo.0800764","article-title":"Predictive value of waist-to-hip ratio on cardiovascular risk events.","volume":"23","author":"Megnien","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2307\/1912934","article-title":"A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity.","volume":"48","author":"White","year":"1980","journal-title":"Econometrica"},{"key":"R47-3-20210128","first-page":"97","article-title":"The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling.","volume":"24","author":"Overall","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v62n1102","article-title":"Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics.","volume":"62","author":"Hagg","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-003-1529-4","article-title":"Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.","volume":"170","author":"Melkersson","year":"2003","journal-title":"Psychopharmacology"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130000639","article-title":"Insulin and leptin levels in patients with schizophrenia or related psychoses-a comparison between different antipsychotic agents.","volume":"154","author":"Melkersson","year":"2001","journal-title":"Psychopharmacology"},{"key":"R52-3-20210128","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.1993.00410180039004","article-title":"Stress and the individual. Mechanisms leading to disease.","volume":"153","author":"McEwen","year":"1993","journal-title":"Arch Intern Med"},{"key":"R53-3-20210128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(03)00177-X","article-title":"Mood disorders and allostatic load.","volume":"54","author":"McEwen","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R54-3-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005053-199102000-00006","article-title":"Psychophysiological responses in the diagnosis of posttraumatic stress disorder in Vietnam veterans.","volume":"179","author":"Blanchard","year":"1991","journal-title":"J Nerv Ment Dis"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1467-789x.2001.00027.x","article-title":"Do stress reactions cause abdominal obesity and comorbidities?","volume":"2","author":"Bjorntorp","year":"2001","journal-title":"Obes Rev"},{"key":"R56-3-20210128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1196\/annals.1367.008","article-title":"Stress, visceral obesity, and metabolic complications.","volume":"1083","author":"Kyrou","year":"2006","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200906000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:14:11Z","timestamp":1618035251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200906000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181a45ed0","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}